Clinical trials
Terminated Primary Myelofibrosis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Astex Pharmaceuticals, Inc. | 1 |
| CTI BioPharma | 1 |
| Celgene | 1 |
| Incyte Corporation | 1 |
| John Mascarenhas | 1 |
| Martin, Paul | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 9 |
| Myeloproliferative Disorders | 5 |
| Leukemia, Myelomonocytic, Chronic | 3 |
| Leukemia, Myeloid, Acute | 2 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2 |
| Leukemia, Myelomonocytic, Juvenile | 2 |
| Leukemia, Neutrophilic, Chronic | 2 |
| Polycythemia Vera | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Thrombocythemia, Essential | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.